Company Overview and News
Pune-based Force Motors is in advanced stages of completing in-house development work on a completely new bus and utility vehicle that will be launched over the course of next two years.
3:30 pm Market Closing: Benchmark indices managed to end near day's high after volatility throughout the session.
1:58 pm Car Price Hike: Toyota Kirloskar Motor (TKM) is planning to increase vehicle prices from next month in order to partially offset rise in input costs.
12:42 pm Market Update: The market is trading mildly lower amid consolidation, after rising in previous 8 consecutive sessions, as investors look for more corporate earnings due over next one and half months.
11:01 am Market Check: Benchmark indices traded with mild gains amid consolidation as investors after digesting normal monsoon forecast look for more corporate earnings.
9:42 am Rupee Trade: The rupee fell 4 paise to 65.53 against the dollar at the interbank forex market.
Pune-based automobile manufacturer Force Motors and Rolls-Royce Power Systems today signed an agreement for a joint venture, in which Force Motors will hold 51 per cent stake and Rolls-Royce Power Systems the balance.
Force Motors today signed its joint venture with Rolls Royce Power Systems, for developing diesel engines and gensets. CNBC-TV18's Uttkarsh Chaturvedi caught up with Prasan Firodia, MD of Force Motors to get more details on the partnership.
3:30 pm Market Closing: The market closed mildly higher amid volatility ahead of two-day US Federal Reserve meeting beginning later in the day.
Rolls Royce Power Systems has tied up with Force Motors to shift the manufacturing base of an engine series for power generation from Germany to India, and thereby reduce costs.
2:40 pm New Telecom Policy: Union Minister Manoj Sinha said the new telecom policy is almost ready and will be brought in the next session of Parliament after a Cabinet nod.
New Delhi: Force Motors Ltd on Tuesday said that it has entered a joint venture agreement with Germany’s MTU Friedrichshafen GmbH, an arm of Rolls-Royce Power Systems AG, to foray into the business of engines.
US car maker General Motors may be on exit mode in India, but in its last year of operations in this country, the company has managed to sell more than some of its foreign and Indian peers. Even in inventory clearing mode, GM sold 2,500 vehicles between April and December 2017, which is more than what Force Motors, Mahindra Electric Mobility, Isuzu Motors were able to sell in the same period. GM exited India in December 2017.
Maruti Suzuki, which rules the domestic car market with a fifty per cent share, is slowly but surely started marking its presence in the new business of light commercial vehicles (LCV or goods carrier). The Suzuki-promoted company had entered the LCV business in July 2016 and is now the fifth player in the segment, though market share is just 2 per cent. The company had sold 460 units of LCV, branded as Super Carry, in the April-January period of FY17.
The Government is planning to come out with two new policies in the auto space -- the first is designed to support the automobile industry as a whole and the second will be focused on electric vehicles. Anant Gangaram Geete, Union Cabinet Minister for Heavy Industries and Public Sector Enterprises, said that the new auto policy will be foolproof and will address all the concerns of the automobile industry.
7h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
8h - Asif
BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...